GlassScriptPhysician profile
Glenn M Dempsey
NPI 1114165719
$1,719.48
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,447 · 2020: $177 · 2021: $95.56.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $1,135.72 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $272.88 | 2020-2021 | |
| Alkermes, INC. | $223.78 | 2019 | |
| Janssen Pharmaceuticals, INC | $87.10 | 2019 |
8 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Dempsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.